Teva/Allergan acquisition: Commission conditional approval | Practical Law
https://content.next.westlaw.com/practical-law/document/I9c00fb780be311e698dc8b09b4f043e0/Teva-Allergan-acquisition-Commission-conditional-approval?viewType=FullText&transitionType=Default&contextData=(sc.Default)
The European Commission has approved the proposed acquisition of the generics business of Allergan plc by Teva, subject to conditions.
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
Teva/Allergan acquisition: Commission conditional approval
Practical Law UK Articles 7-627-0501
(Approx. 2 pages)
Teva/Allergan acquisition: Commission conditional approval
by Clifford Chance LLP
Related Content
Published on 28 Apr 2016
•
European Union,
United Kingdom
The European Commission has approved the proposed acquisition of the generics business of Allergan plc by Teva, subject to conditions.